3 Traits Practitioners Love About ReDS™ When Monitoring Heart Failure Patients
Sensible Medical created the ReDS™ system to measure lung fluid in heart failure patients. ReDS™ was adapted for medical use from the military’s ‘see-through-wall’ technology. Since its introduction, practitioners have been excited about its potential to significantly decrease readmission rates, and increase accuracy and confidence in the monitoring and management of heart failure patients. During the recent HFSA annual event, we had a great opportunity to hear directly from the practitioners about the benefits ReDS™ has to offer. Here are some of the things we heard:
1. “Keep them well, and keep them out of the hospital”
The ReDS™ economic benefit feasibility study presented 87% reduction in hospital readmission rates . As Dr. William Abraham, MD, stated: “We need better tools, like ReDS™, to help us improve patients’ status, keep them well, and keep them out of the hospital.” Dr. Abraham is not the only one convinced that ReDS™ may help in reducing the rehospitalizations of heart failure patients. As Dr. Daniel BenSimhon defined it: “Part of our challenge is how to extend our Heart Failure program out to the community, help other hospitals, and help more people.” For these scenarios, he explained, ReDS™ is a tool in the field, and you can rely on the information it sends back to make treatment decisions.
Sean Pinney, MD, Director, Advanced Heart Failure & Cardiac Transplantation, Mount Sinai Medical Center, said: “As a result of us being able to prescribe the right medicine at the right dosage and at the right time,” patients can enjoy more time out of the hospital, and a better quality of life.
2. Informed Decision support
The ReDS™ System is the decision support tool assisting practitioners in better assessing the status of heart failure patients. As Dr. Abraham put it: “What we’ve needed for a long time is a more accurate and actionable measurement of heart failure clinical status. We get that with ReDS™.” Referring to the benefits ReDS™ can offer for Points of Care, Dr. Daniel BenSimhon, MD, Medical Director, Advanced Heart Failure & Mechanical Circulatory Support Program – Cone Health, said: “It’s an amazing Point of Care device. No other device lets you be portable, lets you go into the home or get a reading at discharge, Point of Care, where the nurse or the paramedic can get an instant, on-the-spot reading. We’re really seeing a unique opportunity for this device. No other device can give us this information.” He concluded.
Whether obtained at an in-person exam or through a remote monitoring service, ReDS™ offers an accurate, absolute, and actionable reading.
3. Non-Invasive, yet highly accurate
Last but not least, in the market today, ReDS™ is unique in the sense of how it is used. A non-invasive vest worn by the patient that delivers a reading in just 90 seconds, ReDS™ is a miniature radar system employing low-power electromagnetic energy that provides accurate lung fluid measurements.
“Previous to ReDS™, all we had was the clinical exam, with the statoscope.” Said Daniel BenSimhon. “The only other option was invasive monitoring. They’d put the catheter in, or we had some other device that was implantable.” He added. On the winning combination of non-invasiveness and accuracy, Dr. BenSimhon said: “We were looking for a technology that would be non-invasive, yet offer accuracy. This search led us to ReDS™.”
These highly favorable impressions of ReDS™ tell us that practitioners truly love the system. ReDS™ offers an accurate, absolute and actionable result, thereby granting practitioners confidence in their decisions. Use of ReDS™ is expected to provide significant health and economic benefits by reducing unnecessary patient hospitalizations and discharges.